SOLVSolventum
What is the market doing?
No clear lean: rangebound and lightly shorted.
Choppy, but holding above its 200-day average. Price is +12% vs its 200-day average.
Lightly shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 13% since the previous count, down from 3.1% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SOLV is trading
Solventum is +17% over the past year while the S&P 500 is +18%: 0.79 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +12%
vs 200-day average · a clear uptrend
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 5.4%
Below its 52-week high
Details›
- Last close2026-10-09
- $87.38
- 1 monthS&P 500 +2.7%
- −0.31%
- 1 yearS&P 500 +18%
- +17%
- vs 50-day average$88.24
- −0.97%
- 52-week high
- $92.40
- 52-week low
- $62.49
- Annualised volatility
- 30%
| Year | Return |
|---|---|
| 2026 (year to date) | +10% |
| 2025 | +20% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 1 of 2 | +4.6% |
| Feb | 2 | 1 of 2 | +2.0% |
| Mar | 2 | 0 of 2 | −8.3% |
| Apr | 3 | 1 of 3 | −5.5% |
| May | 3 | 2 of 3 | +4.4% |
| Jun | 3 | 2 of 3 | −2.1% |
| Jul | 3 | 2 of 3 | +6.5% |
| Aug | 3 | 3 of 3 | +5.7% |
| Sep | 3 | 1 of 3 | +1.8% |
| Oct | 3 | 1 of 3 | −0.74% |
| Nov | 2 | 1 of 2 | +11% |
| Dec | 2 | 0 of 2 | −7.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
The closest names by size in the same industry